Cargando…

Authors’ Reply to Pires et al.: “Switching Reference Medicines to Biosimilars: A Systematic Literature Review of Clinical Outcomes”

Detalles Bibliográficos
Autores principales: Cohen, Hillel P., Blauvelt, Andrew, Rifkin, Robert M., Danese, Silvio, Gokhale, Sameer B., Woollett, Gillian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5993848/
https://www.ncbi.nlm.nih.gov/pubmed/29785563
http://dx.doi.org/10.1007/s40265-018-0919-1
_version_ 1783330298054836224
author Cohen, Hillel P.
Blauvelt, Andrew
Rifkin, Robert M.
Danese, Silvio
Gokhale, Sameer B.
Woollett, Gillian
author_facet Cohen, Hillel P.
Blauvelt, Andrew
Rifkin, Robert M.
Danese, Silvio
Gokhale, Sameer B.
Woollett, Gillian
author_sort Cohen, Hillel P.
collection PubMed
description
format Online
Article
Text
id pubmed-5993848
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-59938482018-06-21 Authors’ Reply to Pires et al.: “Switching Reference Medicines to Biosimilars: A Systematic Literature Review of Clinical Outcomes” Cohen, Hillel P. Blauvelt, Andrew Rifkin, Robert M. Danese, Silvio Gokhale, Sameer B. Woollett, Gillian Drugs Letter to the Editor Springer International Publishing 2018-05-21 2018 /pmc/articles/PMC5993848/ /pubmed/29785563 http://dx.doi.org/10.1007/s40265-018-0919-1 Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Letter to the Editor
Cohen, Hillel P.
Blauvelt, Andrew
Rifkin, Robert M.
Danese, Silvio
Gokhale, Sameer B.
Woollett, Gillian
Authors’ Reply to Pires et al.: “Switching Reference Medicines to Biosimilars: A Systematic Literature Review of Clinical Outcomes”
title Authors’ Reply to Pires et al.: “Switching Reference Medicines to Biosimilars: A Systematic Literature Review of Clinical Outcomes”
title_full Authors’ Reply to Pires et al.: “Switching Reference Medicines to Biosimilars: A Systematic Literature Review of Clinical Outcomes”
title_fullStr Authors’ Reply to Pires et al.: “Switching Reference Medicines to Biosimilars: A Systematic Literature Review of Clinical Outcomes”
title_full_unstemmed Authors’ Reply to Pires et al.: “Switching Reference Medicines to Biosimilars: A Systematic Literature Review of Clinical Outcomes”
title_short Authors’ Reply to Pires et al.: “Switching Reference Medicines to Biosimilars: A Systematic Literature Review of Clinical Outcomes”
title_sort authors’ reply to pires et al.: “switching reference medicines to biosimilars: a systematic literature review of clinical outcomes”
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5993848/
https://www.ncbi.nlm.nih.gov/pubmed/29785563
http://dx.doi.org/10.1007/s40265-018-0919-1
work_keys_str_mv AT cohenhillelp authorsreplytopiresetalswitchingreferencemedicinestobiosimilarsasystematicliteraturereviewofclinicaloutcomes
AT blauveltandrew authorsreplytopiresetalswitchingreferencemedicinestobiosimilarsasystematicliteraturereviewofclinicaloutcomes
AT rifkinrobertm authorsreplytopiresetalswitchingreferencemedicinestobiosimilarsasystematicliteraturereviewofclinicaloutcomes
AT danesesilvio authorsreplytopiresetalswitchingreferencemedicinestobiosimilarsasystematicliteraturereviewofclinicaloutcomes
AT gokhalesameerb authorsreplytopiresetalswitchingreferencemedicinestobiosimilarsasystematicliteraturereviewofclinicaloutcomes
AT woollettgillian authorsreplytopiresetalswitchingreferencemedicinestobiosimilarsasystematicliteraturereviewofclinicaloutcomes